SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Shiba Inu (SHIB) is a decentralized, community-led cryptocurrency ecosystem built on the Ethereum blockchain. Originally launched as a meme-based project, it has evolved into a comprehensive financial ecosystem designed to offer a decentralized alternative to traditional banking. Its main value proposition lies in its transition from a social phenomenon into a functional utility network, supported by a vast global community known as the ShibArmy and a commitment to 100% community ownership with no central leadership.  The ecosystem features its own decentralized exchange, ShibaSwap, where users can trade, provide liquidity, and earn rewards. To address Ethereum’s high costs and slow speeds, the project utilizes Shibarium, a Layer 2 scaling solution that processes transactions faster and more affordably.  The project employs a unique three-token model to manage its economy and governance. SHIB serves as the primary currency for trading and payments, while LEASH offers scarcity-based incentives for dedicated supporters. BONE acts as the governance token, allowing holders to vote on proposals through the Doggy DAO and serving as the native gas token for the Shibarium network.

Shiba Inu

Shiba Inu is trending as the community actively debates whether the project's evolution into a broader ecosystem justifies its current valuation or if it remains a speculative play. Investors are heavily divided, with some pointing to token burns and Shibarium utility as long-term catalysts, while others express frustration over stagnant price action and the ongoing influence of meme culture.

PENGU is the official coin of Pudgy Penguins.  Pudgy Penguins has become the face of crypto with one of the most influential communities in the industry. From large companies wearing the Penguin, to being featured in ETF commercials, to garnering millions of followers and over 100 billion views, the Pengu has become a cultural icon making PENGU the world’s social currency.  PENGU allows for the ever-expanding Pudgy Penguin fanbase and the hundreds of millions of people outside of crypto that see and share the Pudgy Penguin everyday, to join The Huddle. PENGU is a symbol for community, memes, and good vibes.  Believe in Pengu. Believe in the Prophecy.

Pudgy Penguins

Pudgy Penguins is trending as investors debate its long-term potential compared to other memecoins, with many in the community focused on aggressive accumulation strategies despite recent price volatility. While some participants express frustration over stagnant performance, others remain bullish on the brand's retail expansion and IP-driven model as a catalyst for future growth.

The Ondo Foundation was founded in 2022 as an independently governed and nonprofit Cayman Islands Foundation Company with no beneficial owners. The Ondo Foundation assisted in the launch of the Ondo DAO, which deployed and currently governs Flux Finance, the first lending protocol supporting tokenized securities as collateral.  ONDO token holders are entrusted with shaping the future of the Ondo DAO so that it continues to pursue its mission to democratize access to institutional-grade finance. The Ondo DAO gives ONDO holders specific rights pertaining to Flux Finance, which is currently governed by the Ondo DAO.

Ondo

Ondo is seeing increased market attention as investors speculate on the potential for institutional RWA adoption, with the community actively discussing governance and the possibility of future fee structures. While supporters highlight the project's leadership in the tokenization space, others express caution regarding price volatility and the long-term impact of governance-only tokenomics.

Centrus Energy Corp. engages in the supply of nuclear fuel and services for the nuclear power industry. It operates through the Low-Enriched Uranium (LEU) and Technical Solutions segments. The LEU segment includes various components of nuclear fuel to utilities from its global network of suppliers. The Technical Solutions segment offers advanced engineering, design, and manufacturing services to government and private sector customers, and is deploying advanced nuclear fuel production capabilities to power existing, and next-generation reactors around the world. The company was founded in October 1992 and is headquartered in Bethesda, MD.

Centrus Energy Corp - Ordinary Shares - Class A

Centrus Energy Corp 

Centrus Energy is trending as investors weigh its unique position as the sole licensed U.S. producer of HALEU nuclear fuel against technical volatility and institutional sell-offs. The community is heavily focused on its role as a critical infrastructure "toll booth" for the AI energy supercycle, while traders remain divided over whether to capitalize on recent dips or wait for a confirmed trend reversal amid broader nuclear sector consolidation.

Sigma Lithium Corp. engages in the producing of a lithium property. It focuses its project in Minas Gerais. The firm also plans to build a world-class commercial-scale lithium concentration plant. The company was founded on June 8, 2011 and is headquartered in Sao Paulo, Brazil.

Sigma Lithium Corporation

Sigma Lithium is seeing heightened volatility as the community debates the stock's long-term potential against a backdrop of aggressive short-seller campaigns and conflicting regulatory reports. While some investors focus on optimistic production expansion plans and the company's status as a low-cost operator, others are expressing frustration over persistent downward price pressure and the ongoing uncertainty surrounding the mining permit landscape.

Dogecoin is an open-source digital currency based on the "Doge" meme that functions as a peer-to-peer medium for fast payments and digital tipping. Unlike projects backed by corporate entities, its value is driven by a global community, and the project is managed by a decentralized group of volunteers and the non-profit Dogecoin Foundation rather than a formal company.  Originally created in 2013 by software engineers Billy Markus and Jackson Palmer as a market parody, the project held no public sale or venture capital rounds. The network operates as a fork of LuckyCoin, which itself was a fork of Litecoin, using a proof of work consensus mechanism. It employs the Scrypt algorithm to ensure the mining process remains fast and efficient, with new blocks processed every 60 seconds. A unique technical feature is its use of merged mining, allowing miners to secure Dogecoin simultaneously with other Scrypt-based networks like Litecoin.  To keep transaction fees low and the network running indefinitely, Dogecoin features an uncapped supply where new coins are added forever. In a major regulatory milestone in March 2026, a joint SEC and CFTC framework officially classified Dogecoin as a digital commodity, placing it in the same asset category as gold or oil.

Dogecoin

Dogecoin is facing heightened community debate as participants oscillate between bullish long-term sentiment tied to high-profile endorsements and intense skepticism regarding its utility and price action. While some traders continue to hunt for meme-driven rallies, others are actively rotating capital into alternative tokens or shorting the asset amidst widespread frustration with stagnant momentum.

JasmyCoin is based on the ERC 20 standard. The token can also be used by an unspecified number of individuals and businesses to transfer tokens using digital devices as proof of value exchange or payment for services. By not limiting its usability, the token can have a wide range of purposes.

JasmyCoin

JasmyCoin is trending as the community remains deeply polarized, with bulls pointing to ecosystem expansion and potential regulatory shifts in Japan while vocal critics cite concerns over project abandonment and the rise of related tokens like Janction. The ongoing debate centers on whether the current price action represents an institutional accumulation phase or a long-term decline in a project that some investors argue has failed to deliver on its original utility promises.

Select Sector SPDR Trust (The) - State Street Energy Select Sector SPDR ETF

Energy Select Sector SPDR Fund

XLE is trending as institutional investors closely watch a combination of supply-chain disruptions in the Strait of Hormuz and depleting global oil inventories that are pressuring markets. Community discourse remains focused on geopolitical volatility and the potential for a long-term structural supply deficit, with many traders analyzing technical patterns and bullish options flows to identify a potential rebound.

Summit Therapeutics, Inc. is a biopharmaceutical company, that focuses on the discovery, development, and commercialization of patient, physician, caregiver, and societal-friendly medicinal therapies intended to improve quality of life, increase potential duration of life, and resolve serious unmet medical needs. The firm conducts clinical programs focusing on Clostridioides Difficile Infection (CDI). Its lead product, Ridinilazole, is an orally administered small molecule antibiotic that is in Phase III clinical trials for the treatment of CDI. The company was founded in 2003 and is headquartered in Miami, FL.

Summit Therapeutics Inc

Summit Therapeutics is driving significant market conversation as investors await the upcoming ASCO plenary presentation on Sunday, which will reveal late-breaking survival data for its ivonescimab lung cancer treatment. The community is actively debating the significance of the data and potential regulatory hurdles, while observing heavy insider accumulation and strategic positioning as a key catalyst for the company's valuation.

Direxion Shares ETF Trust - Direxion Daily MSCI South Korea Bull 3X ETF

Direxion Daily South Korea Bull 3X Shares

KORU is trending due to extreme volatility in South Korean semiconductor stocks, driven by a wave of margin call liquidations among highly leveraged retail investors. Community sentiment is deeply divided, with many traders viewing the current pullback as a temporary opportunity to buy memory chip leaders, while others caution that the combination of geopolitical tensions and excessive retail leverage suggests further downside potential.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Wall Street Analysts Think Arcutis Biotherapeutics (ARQT) Could Surge 25.79%: Read This Before Placing a Bet

The mean of analysts' price targets for Arcutis Biotherapeutics (ARQT) points to a 25.8% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

Arcutis Biotherapeutics (NASDAQ:ARQT) Releases Quarterly Earnings Results, Misses Expectations By $0.07 EPS

Arcutis Biotherapeutics (NASDAQ:ARQT - Get Free Report) posted its earnings results on Wednesday. The company reported ($0.09) EPS for the quarter, missing the consensus estimate of ($0.02) by ($0.07). Arcutis Biotherapeutics had a negative return on equity of 10.26% and a negative net margin of...

Arcutis Biotherapeutics (NASDAQ:ARQT) Insider Todd Watanabe Sells 3,172 Shares

Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT - Get Free Report) insider Todd Watanabe sold 3,172 shares of the company's stock in a transaction dated Monday, May 4th. The shares were sold at an average price of $23.61, for a total value of $74,890.92. Following the sale, the insider owned 720,755...

Arcutis Biotherapeutics (NASDAQ:ARQT) CFO Sells $31,661.01 in Stock

Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT - Get Free Report) CFO Latha Vairavan sold 1,341 shares of the stock in a transaction on Monday, May 4th. The shares were sold at an average price of $23.61, for a total value of $31,661.01. Following the completion of the transaction, the chief financial...

Arcutis Biotherapeutics (NASDAQ:ARQT) Insider Patrick Burnett Sells 684 Shares of Stock

Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT - Get Free Report) insider Patrick Burnett sold 684 shares of the company's stock in a transaction that occurred on Monday, May 4th. The shares were sold at an average price of $23.61, for a total value of $16,149.24. Following the completion of the...

Arcutis Biotherapeutics Q1 Earnings Call Highlights

Arcutis Biotherapeutics (NASDAQ:ARQT) reported first-quarter 2026 net product revenues of $105.4 million, a 65% increase versus the same period last year, as the company pointed to continued demand growth for its topical therapy ZORYVE and progress across a "grow, expand, build" strategy that includ...

Arcutis Biotherapeutics, Inc. (ARQT) Reports Q1 Loss, Beats Revenue Estimates

Arcutis Biotherapeutics (ARQT) delivered earnings and revenue surprises of -438.92% and +6.30%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT) Given Average Recommendation of "Moderate Buy" by Brokerages

Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT - Get Free Report) has earned a consensus rating of 'Moderate Buy' from the eight brokerages that are covering the firm, MarketBeat.com reports. One...

Insider Selling: Arcutis Biotherapeutics (NASDAQ:ARQT) Director Sells 7,144 Shares of Stock

Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT - Get Free Report) Director Howard Welgus sold 7,144 shares of the firm's stock in a transaction that occurred on Friday, May 1st. The shares were sold at an average price of $22.99, for a total value of $164,240.56. Following the completion of the sale...

Pictet Asset Management Holding SA Buys 74,528 Shares of Arcutis Biotherapeutics, Inc. $ARQT

Pictet Asset Management Holding SA lifted its stake in shares of Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT - Free Report) by 566.4% during the fourth quarter, according to the company in its most...

Arcutis Biotherapeutics, Inc. engages in the development and commercialization of treatments for dermatological diseases. Its pipeline consists of topical treatments for plaque psoriasis, atopic dermatitis, hand eczema, vitiligo, scalp psoriasis, alopecia areata, and seborrheic dermatitis. The company was founded by Bhaskar Chaudhuri and David W. Osborne in June 2016 and is headquartered in Westlake Village, CA.

Arcutis Biotherapeutics Inc

Arcutis Biotherapeutics Sees 400% Spike In Retail Buzz As Q4 Beat Fuels After-Hours Rally

Equity

Bullish Sentiment

Up more than 1%

Flat to up 1%

Flat to down 1%

Down more than 1%

The S&P 500 ($SPY) is headed towards another losing week. What do you think the index's return will look like next week? Vote and explain your reasoning in the comments.

What do you think the S&amp;P 500&#39;s ($SPY) return will be next week?

Feed

News

Sentiment

Earnings

Fundamentals

Info

ARQTArcutis Biotherapeutics Inc

Fundamentals

Latest ARQT News